Identifying TP53RK as a key regulator of colorectal cancer survival and a potential therapeutic targetYoung Hee Choi(Dongguk University), Tae‐You Kim(Seoul National University of Science and Technology)Scientific ReportsOctober 16, 202510.1038/s41598-025-21082-7Cited by 1SaveCiteExport RISWatch citationsRelated PapersPatient‐derived organoids as a preclinical platform for precision medicine in colorectal cancer|Molecular Oncology|2021|43<scp>FGFR</scp>2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers <i>in vitro</i>|Molecular Oncology|2018|33